Inspired by the speed and ease of at-home Covid-19 tests, OncoSwab is developing a test for lung cancer that detects signs of the disease from a nasal swab. The test could become an alternative to the ...

Cortica's $80 million raise was co-led by Morgan Health and Nexus NeuroTech Ventures and included participation from Autism ...

Endoscopy, the standard for detecting esophageal precancer, is quite an invasive procedure — so a lot of people who should be ...

Welcome back to another episode of MedCity FemFwd, a podcast dedicated to discussing the breakthroughs and challenges in women’s health. In this episode, we’re joined by Dr. Piraye Yurttas ...

Several healthcare leaders are showing their support for the Biden-Harris Administration’s new proposed rule that would expand coverage of GLP-1s for those with Medicare and Medicaid. Medicare ...

A BridgeBio Pharma drug developed for an increasingly prevalent cardiovascular condition has won FDA approval, marking a comeback for a company and a molecule with a turbulent history. But ...

Health systems across the country are scaling hybrid and home-based care models by integrating virtual visits with in-person services, deploying remote monitoring technologies, and partnering with ...

AbbVie schizophrenia drug candidate emraclidine failed to beat a placebo in two Phase 2 clinical trials. The drug, once projected to compete with Bristol Myers Squibb’s Cobenfy, is from AbbVie ...

Synapticure, a virtual care company for neurodegenerative diseases, has secured $25 million in Series A funding to scale its services and expand its partnerships with health systems, payers and ...

This is the 22nd and final episode of the MedCity Moves podcast. Moving forward, Senior Reporter Katie Adams will continue to publish a roundup article at the end of each month listing recent ...

The healthcare industry’s movement away from fee-for-service care models and toward value-based care has been an incredibly gradual process. Contracting in these arrangements remains difficult ...